176 related articles for article (PubMed ID: 11967632)
1. Inhibition by sigma receptor ligand, MS-377, of N-methyl- D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area.
Yamazaki Y; Ishioka M; Matsubayashi H; Amano T; Sasa M
Psychopharmacology (Berl); 2002 Apr; 161(1):64-9. PubMed ID: 11967632
[TBL] [Abstract][Full Text] [Related]
2. MS-377, a selective sigma receptor ligand, indirectly blocks the action of PCP in the N-methyl-D-aspartate receptor ion-channel complex in primary cultured rat neuronal cells.
Karasawa J; Yamamoto H; Yamamoto T; Sagi N; Horikomi K; Sora I
Life Sci; 2002 Feb; 70(14):1631-42. PubMed ID: 11991251
[TBL] [Abstract][Full Text] [Related]
3. Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons.
Hayashi T; Kagaya A; Takebayashi M; Shimizu M; Uchitomi Y; Motohashi N; Yamawaki S
J Pharmacol Exp Ther; 1995 Oct; 275(1):207-14. PubMed ID: 7562551
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
Whittemore ER; Ilyin VI; Woodward RM
J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
[TBL] [Abstract][Full Text] [Related]
6. Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area.
Schwieler L; Linderholm KR; Nilsson-Todd LK; Erhardt S; Engberg G
Life Sci; 2008 Aug; 83(5-6):170-5. PubMed ID: 18590745
[TBL] [Abstract][Full Text] [Related]
7. Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors.
Debonnel G; Bergeron R; de Montigny C
J Endocrinol; 1996 Sep; 150 Suppl():S33-42. PubMed ID: 8943785
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of N-methyl-D-aspartate receptors by haloperidol: developmental and pharmacological characterization in native and recombinant receptors.
Lynch DR; Gallagher MJ
J Pharmacol Exp Ther; 1996 Oct; 279(1):154-61. PubMed ID: 8858988
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala.
Pickel VM; Colago EE; Mania I; Molosh AI; Rainnie DG
Neuroscience; 2006 Oct; 142(3):671-90. PubMed ID: 16905271
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area.
Prieto-Gómez B; Vázquez-Alvarez AM; Martínez-Peña JL; Reyes-Vázquez C; Yang PB; Dafny N
Life Sci; 2005 Jun; 77(6):635-49. PubMed ID: 15921995
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL.
Grauert M; Rho JM; Subramaniam S; Rogawski MA
J Pharmacol Exp Ther; 1998 May; 285(2):767-76. PubMed ID: 9580625
[TBL] [Abstract][Full Text] [Related]
12. In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands.
Monnet FP; Debonnel G; de Montigny C
J Pharmacol Exp Ther; 1992 Apr; 261(1):123-30. PubMed ID: 1532832
[TBL] [Abstract][Full Text] [Related]
13. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus.
Bermack JE; Debonnel G
Synapse; 2005 Jan; 55(1):37-44. PubMed ID: 15499608
[TBL] [Abstract][Full Text] [Related]
14. Effects of sigma(1) receptor ligand MS-377 on D(2) antagonists-induced behaviors.
Karasawa J; Takahashi S; Takagi K; Horikomi K
Pharmacol Biochem Behav; 2002 Oct; 73(3):505-10. PubMed ID: 12151023
[TBL] [Abstract][Full Text] [Related]
15. Nefiracetam potentiates N-methyl-D-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor.
Moriguchi S; Shioda N; Maejima H; Zhao X; Marszalec W; Yeh JZ; Fukunaga K; Narahashi T
Mol Pharmacol; 2007 Feb; 71(2):580-7. PubMed ID: 17095583
[TBL] [Abstract][Full Text] [Related]
16. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
Gronier B; Debonnel G
Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
[TBL] [Abstract][Full Text] [Related]
17. Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.
Schwieler L; Engberg G; Erhardt S
Synapse; 2004 May; 52(2):114-22. PubMed ID: 15034917
[TBL] [Abstract][Full Text] [Related]
18. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
[TBL] [Abstract][Full Text] [Related]
19. [Modulation of neuronal activities in the central nervous system via sigma receptors].
Ishihara K; Sasa M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Feb; 22(1):23-30. PubMed ID: 11917506
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
